Skip to main content
Premium Trial:

Request an Annual Quote

Canada Renews Funding for Genomics Research Initiative

NEW YORK (GenomeWeb) – The Canadian government today said it is renewing a genomics research initiative with C$99.5 million (US$93.3 million) in funding for the next five years.

The funding for the program, called the Genomics Research and Development Initiative, will be used to support research in agriculture, environment, fisheries, forestry, and health. GRDI was created in 1999 and coordinates genomics research among eight federal science departments and agencies, including the National Research Council of Canada; Agriculture and Agri-Food Canada; Health Canada; Fisheries and Oceans; the Canada Food Inspection Agency; Environment Canada; Natural Resources Canada; and the Public Health Agency of Canada.

In 2011 the GRDI received C$59.7 million in funding for three years.

"The GRDI increases our understanding of a wide range of genomic questions and supports discoveries in critical areas like healthcare, agriculture, forestry, and fisheries to the benefit of communities at home and around the world," Canada's Minister of State for Science and Technology Ed Holder said in a statement.

Filed under

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.